Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Efficiency Provision Process Assistive Devices for Donning and Doffing Compression Hosiery (#HASHTEK)

3. Juni 2026 aktualisiert von: Loek van der Heide, Zuyd University of Applied Sciences

Efficiency of an Optimized Process of Providing Assistive Devices for Donning and Doffing Compression Hosiery

OBJECTIVE:

  1. To optimize the process of providing assistive devices for donning and doffing compression hosiery.
  2. To evaluate effects and cost-effectiveness.

METHOD:

A cluster randomized controlled trial. Participants are recruited through the participating fitter of compression hosiery. The new method and associated tools will be developed in year 1 in 6 co-creation meetings with all stakeholders.

After development, the protocol is used by half of the participating suppliers of compression hosiery. For this purpose, a vocational training will be developed and provided in the project.

CARE AS USUAL:

Earlier research has provided insight into bottlenecks in the current method of providing devices for donning and doffing compression hosiery. Currently, the process is not standardized.

ECONOMIC EVALUATION:

According to Dutch guidelines as a combination of CEA and CUA from a societal perspective. Primary outcome measure CUA: incremental costs per extra QUALY based on the EQ-5D-5L. Costs healthcare, compression stockings user and family, as well as other costs (e.g. productivity) outside the healthcare sector will be included.

DISEASES:

The study population involves a heterogeneous group of individuals with various diseases such as chronic venous insufficiency, lymphedema, venous ulcer cruris, thrombosis.

HYPOTHESIS:

It is hypothesized that an optimized provision process with more involvement of users/wearers of compression hosiery, and better selection of assistive devices and training, positively contributes to compliance, satisfaction, independence, autonomy, participation and QoL of compression hosiery wearers. An optimized provision process is expected to be cost-effective.

Studienübersicht

Status

Abgeschlossen

Detaillierte Beschreibung

OBJECTIVE:

  1. To optimize the process of providing assistive devices for donning and doffing compression hosiery, resulting in a better quality of life (QoL) for users of compression stockings, less burden on informal caregivers and homecare and substantial savings in healthcare costs.
  2. To evaluate effects and cost-effectiveness.

METHOD:

A cluster randomized controlled trial, controlled trial with a 1:1 allocation of participants in the intervention and in the control group. Participants in both groups are recruited through the participating fitter of compression hosiery. The recruiters in the intervention group work together with occupational therapists according to the developed optimized method for the providing process. The new method and associated tools will be developed in year 1 in 6 co-creation meetings with all stakeholders.

The new method follows the steps described in the RiFA and will be defined in a protocol. After development, the protocol is used by half of the participating suppliers of compression hosiery and the occupational therapists with whom they collaborate. For this purpose, a vocational training will be developed and provided in the project, and the protocol and associated tools will be made available digitally.

CARE AS USUAL:

Earlier research has provided insight into bottlenecks in the current method of providing devices for donning and doffing compression hosiery. Currently, the process is not standardized; not everyone who would benefit is entering the process, professionals do not have sufficient knowledge about the assistive devices, the cooperation between client, supplier and care professional often does not go well, the match between the device, client and environment is often not sufficient, reimbursement is not adequate and the evaluation is limited.

ECONOMIC EVALUATION:

According to Dutch guidelines as a combination of CEA and CUA from a societal perspective. In the CEA, the ICER is expressed as the incremental costs per improvement on the success rate. Primary outcome measure CUA: incremental costs per extra QUALY based on the EQ-5D-5L. Costs healthcare, compression stockings user and family, as well as other costs (e.g. productivity) outside the healthcare sector will be included. All relevant data are collected with a tailored cost questionnaire.

DISEASES:

The study population involves a heterogeneous group of individuals with various diseases such as chronic venous insufficiency, lymphedema, venous ulcer cruris, thrombosis.

HYPOTHESIS:

It is hypothesized that an optimized provision process with more involvement of users/wearers of compression stockings, and better selection of assistive devices and training, positively contributes to compliance, satisfaction, independence, autonomy, participation and QoL of compression hosiery users/wearers. In addition, an optimized provision process is expected to be cost-effective. In the short term, this will lead to higher costs for services and assistive devices (e.g., additional use of occupational therapy for selection of the devices, instruction and training, possibly provision of more expensive devices and careful evaluation), but the costs of home care (and indirect costs for informal care) and the treatment of complications will decrease.

Studientyp

Interventionell

Einschreibung (Tatsächlich)

220

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

    • Limburg
      • Heerlen, Limburg, Niederlande, 6419 DJ
        • Zuyd University of Applied Sciences

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

  • Erwachsene
  • Älterer Erwachsener

Akzeptiert gesunde Freiwillige

Nein

Beschreibung

Inclusion Criteria:

  • Adults (18 years or older)
  • Living at home
  • Long-term indication for compression stockings with compression class II (23-32 mmHg), III (34-46 mmHg) and IV (>46 mmHg)
  • First delivery of the compression stockings
  • Supplier estimates that donning/doffing without an assistive devise is difficult or impossible This group is heterogeneous regarding indication for compression stockings and secondary problems.

Exclusion Criteria:

  • < 18 years old
  • Cognitive problems
  • Difficulties to understand Dutch language
  • Short-term indication for compression stockings
  • Pregnancy

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Versorgungsforschung
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Doppelt

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Kein Eingriff: Pflege wie gewohnt
Experimental: Optimized provision process
Optimized method for the provision of assistive technology devices for doffing and donning compression hosiery.
The new method is developed based on a generic quality framework for the provision of AT in the Netherlands.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Adherence to the use of an assistive product for donning and/or doffing compression hosiery
Zeitfenster: 12 months
Use of the assistive device for donning and doffing compression hosiery, defined as percentage of days in 12 months (the duration of the study) on which participants don or doff their compression hosiery with the use of an assistive device. The percentage will be compared between both groups (intervention and control group (care as usual)). The use of assistive devices for donning and doffing compression hosiery will be measured every month during one week by means of a (digital or paper) diary. The digital diary can be filled in with the Samply app or Questback.
12 months

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
D-QUEST (Dutch version of the Quebec User Evaluation of Satisfaction with Assistive Technology)
Zeitfenster: 12 months

The Dutch version of the Quebec User Evaluation of Satisfaction with Assistive Technology (D-QUEST) measures the satisfaction of an assistive technology user with a provided assistive device. The Dutch version consists of 12 items that are scored on a 5-point scale. 1= not satisfied at all and 5 = very satisfied. Users are asked to indicate how satisfied or dissatisfied they are with each aspect. Respondents can indicate their degree of satisfaction or dissatisfaction with the various aspects using the multiple-choice answers below. If they are not satisfied, they will be asked for the reason why (free text field).

A high score on the D-QUEST corresponds to a high level of satisfaction. The D-QUEST can be used at an individual level as a "clinical instrument" to evaluate an individual provision. In other words, as part of the care process and with the aim of optimizing that provision.

12 months
IPPA
Zeitfenster: 12 months
Individually Prioritised Problem Assessment (IPPA) assesses the effectiveness of assistive technology provision. It is a generic instrument that can be used to assess the extent to which problems identified by an individual assistive technology user have been diminished. This study only asks about the activities of donning and doffing compression hosiery. At the start of the service delivery process, the client is asked to identify and rate the problems with donning and doffing the compression hosiery (no difficulty at all= 1, too much difficulty to perform = 5), and the importance of the activity (not relevant = 1, very relevant = 5). The same activities are rated again, a few months after receiving a new assistive technology. It measures the reduction in problems experienced during daily activities before and after the provision of the device, in this case donning CH. A negative score indicates that the problems have worsened. A positive score indicates the problems have decreased.
12 months
Autonomy
Zeitfenster: 12 months

The in-house developed questionnaire on autonomy covers six main questions, three relating to donning and three to doffing. For each main question, respondents are asked whether they can decide on this themselves. If the answer is no or not always, they are asked whether this is caused by donning or doffing CH. Respondents are only asked to what extent they experience this as a problem if the answer to the previous question is yes.

The main questions related to donning:

  • Can you decide for yourself what time you get up?
  • Can you decide how you spend your morning if you stay at home?
  • Can you participate in planned activities outside the home in the morning?

The main questions related to doffing are:

  • Can you decide what time you go to bed?
  • Can you decide how to spend your evenings if you stay at home?
  • Can you take part in organized activities outside the home in the evening?
12 months
iPCQ
Zeitfenster: 12 months
The iMTA Productivity Cost Questionnaire (iPCQ) asks questions on time spent with (unpaid) work, absenteeism and support of informal caregivers for unpaid work/productivity during the last 4 weeks
12 months
KWAZO [Kwaliteit van Zorg]
Zeitfenster: 12 months
KWAZO [Kwaliteit van Zorg; Quality of Care] is a questionnaire to assess the quality of an assistive technology provision process from a client's perspective. KWAZO has decent measurement properties, and its self-report format makes it an easy-to-use tool for assessment of the quality of assistive technology provision. The KWAZO asks seven questions about patient satisfaction with the process of providing medical aids. Patients can answer the questions with "inadequate = 1" "adequate = 2", or "good =3". Total score: wise score (7-21), where a high score indicates a high degree of satisfaction with the device provided.
12 months
EQ-5D-5L
Zeitfenster: 12 Months
Health-related quality of life is measured using the EuroQol EQ-5D-5L questionnaire at baseline and three follow-up time points (T0-T3). Responses across the five EQ-5D dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression). The EQ-5D-5L consists of five items. For each item, participants rated the extent of their problems from "no problems =1" to "extreme problems = 5"
12 Months
iMCQ
Zeitfenster: 12 months
The iMTA Medical Consumption Questionnaire (iMCQ) is an instrument for measuring medical consumption. The iMCQ includes questions on type and number of appointments with health care professionals in the last 4 months, type and number of received treatment, support or other social and health care interventions. The iMCQ is a generic questionnaire. It is therefore not disease specific. In other words, reference is made to healthcare consumption due to illness, disability or psychiatric problems, without specifying a particular disease.
12 months

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

6. Februar 2023

Primärer Abschluss (Tatsächlich)

1. April 2025

Studienabschluss (Tatsächlich)

1. April 2025

Studienanmeldedaten

Zuerst eingereicht

20. März 2023

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

3. Juni 2026

Zuerst gepostet (Tatsächlich)

9. Juni 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

9. Juni 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

3. Juni 2026

Zuletzt verifiziert

1. Juni 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Andere Studien-ID-Nummern

  • 80-87500-98-21103

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

JA

Beschreibung des IPD-Plans

IPD plan description: Individual clinical trial participant-level data will be published open access anonymously. Data with pseudonyms will be sent on request on certain conditions.

IPD-Sharing-Zeitrahmen

Form March 6th 2026 until March 2041

IPD-Sharing-Zugriffskriterien

Anonymized data is free available via DataVerse

Art der unterstützenden IPD-Freigabeinformationen

  • STUDIENPROTOKOLL
  • SAFT
  • ICF
  • CSR

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Klinische Studien zur Optimized provision process

Abonnieren